FDA Proposes First Major Update to Infant Formula Nutrient Levels in Decades

by admin
FDA Proposes First Major Update to Infant Formula Nutrient Levels in Decades

The FDA proposed new iodine, manganese, vitamin A and vitamin D levels for infant formula. Comments are due Feb. 26, 2027.

The US Food and Drug Administration (FDA) has proposed new nutrient levels for infant formula, its first broad update in nearly 30 years. Formula makers would get three years after a final rule to reformulate and relabel, and comments are due Feb. 26, 2027.

The FDA published the proposed rule on Oct. 29, 2026, as the first of three planned rules reviewing the 30 nutrients that formula sold in the US must contain1. It would change limits for iodine, manganese, vitamin A and vitamin D, and keep current limits for chloride, potassium, selenium and sodium2. The FDA plans to combine all three phases into one final rule1.

At a glanceDetails
What was publishedProposed rule on infant formula nutrient requirements (phase 1 of 3)
Published on29 October 2026
Who can comment / Who must complyPublic may comment; domestic and foreign formula makers would comply
Feedback deadline / Effective dateComments due 26 February 2027
Final rules / Next milestoneTwo more proposed rules, then one combined final rule

Why the FDA is updating formula rules

Federal law sets binding minimum and maximum nutrient levels for all infant formula sold in the US3. Formula that misses those levels counts as adulterated, meaning it breaks food safety law, and may not be sold3. The FDA’s last comprehensive review of formula nutrients took place in 19981.

The proposal in brief

DimensionProvision
ScopeInfant formula sold in the US, except certain exempt formula
Nutrients changedIodine, manganese, vitamin A, vitamin D
Nutrients keptChloride, potassium, selenium, sodium
Comment deadline26 February 2027
Compliance3 years after final rule takes effect

Some current limits are even older. The iodine minimum and the iodine and vitamin A maximums date to a 1985 rule3. A 2022 law requires the FDA to review the nutrient table every four years, as appropriate3.

The FDA says the changes are not driven by safety concerns1. It says formula now on the market remains safe for babies1.

What changes for each nutrient

The proposal sets levels per 100 kilocalories (kcal), a standard serving measure based on the formula’s energy content1. The biggest change is for vitamin D, where both the floor and ceiling would rise1.

NutrientCurrent levelProposed level
Iodine5 to 75 µg per 100 kcal15 to 50 µg per 100 kcal
ManganeseMinimum 5 µg, no maximum1 to 50 µg per 100 kcal
Vitamin A75 to 225 µg RAE per 100 kcal70 to 120 µg RAE per 100 kcal
Vitamin D1 to 2.5 µg per 100 kcal2 to 3 µg per 100 kcal

The rule would also measure vitamins A and D in micrograms instead of International Units (IU)1. Only preformed vitamin A would count toward vitamin A limits, not beta-carotene1. Labels would be updated to match the new levels1.

Limits for chloride, potassium, selenium and sodium would stay the same1. The FDA is not proposing to add or remove any required nutrient in this phase1.

How many products may need new recipes

The FDA’s registry lists 222 formulations on the US market, including 75 exempt formulas3. The rule would apply to products that meet the legal definition of infant formula, except certain exempt formulas1.

The FDA estimates that all 222 formulations may need changes to meet the new vitamin D range3. About 20 may need iodine changes, 13 vitamin A changes and one a manganese change3.

Costs and benefits for industry and families

Manufacturers would bear one-time costs for relabeling, reformulation and paperwork filed with the FDA3. The agency puts annualized costs at $17.6 million, its main estimate at a 7% discount rate3.

Yearly estimates at a 7% discount rate

$17.6 million Annualized cost to manufacturers
$80.9 million Annualized benefits

It estimates annualized benefits of $80.9 million at the same rate, mainly from avoided health costs linked to low vitamin D3. Benefits would start in 2032, after the proposed three-year compliance period3.

Benefits are expected to go largely to infants in WIC, the federal nutrition program for low-income families3. These infants make up about 50% of formula-fed babies in the US3. The FDA says the proposal will not have an immediate effect on WIC1.

Next phases and compliance timeline

Two more proposed rules will follow1. Phase 2 covers 12 vitamins and related nutrients, including vitamin C, B vitamins and choline1. Phase 3 covers protein, fat, iron, calcium and other minerals, plus carbohydrate sources1.

The FDA is also asking for comments on nutrients makers often add but are not required, such as DHA and ARA, two fatty acids, and L-carnitine2. An outside organization is reviewing the phase 3 evidence1.

Key dateWhat happens
29 October 2026Phase 1 proposed rule published
26 February 2027Comment deadline
60 days after final ruleCombined final rule takes effect
3 years after effective dateFormula must meet new levels

Comments go to docket FDA-2026-N-10832, the FDA’s public file for the rule1.

Key terms in plain words

TermMeaning
Proposed ruleA draft regulation released for public comment before it becomes final
Exempt infant formulaA category of formula, certain types of which the rule would not cover
µg RAEMicrograms of retinol activity equivalents, a way to measure vitamin A
Per 100 kcalAmount of a nutrient for every 100 kilocalories of formula
Compliance dateThe deadline by which products must meet the new rules
AdulteratedA food that breaks federal safety rules and cannot legally be sold

The public can comment on the proposal until Feb. 26, 20272.

Sources

  1. ↩ Infant Formula Notice of Proposed Rulemaking Infant Formula Nutrient Requirements | FDA https://www.fda.gov/food/infant-formula-homepage/infant-formula-notice-proposed-rulemaking-infant-formula-nutrient-requirements
  2. ↩ Trump Administration Announces First Major Update to Infant Formula Standards in Nearly 30 Years | HHS.gov https://www.hhs.gov/press-room/fda-updates-infant-formula-standards-first-time-30-years.html
  3. ↩ Infant Formula Phase 1 PRIA 508 Compliant https://www.fda.gov/media/196128/download

You may also like